¥24.32   ( %)
前日收盘: 当日成交量(股): 当日最高: 总股本:3749.58万
当日开盘: 当日成交额(元): 当日最低: 流通股本:
市盈率(动/静):0/0 市净率:0 市销率:0 总市值:9.12亿
52周最高:26.50 52周最低:15.07 转让方式: 单位:美元
$Homology Medicines(FIXX)$
  • 还可以输入
  • 20016

Homology Medicines(FIXX) 11月28日 11时20分

公告 Homology Medicines, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:PARMAR KUSH
公告日:2018-11-27, 内部交易人:PARMAR KUSH, 与发行人关系:董事/10%持股人/, 操作:卖出,29682(股)Common Stock,均价$20.0360; 报告日:2018-11-23, SEC Accession No. 0001104659-18-070149, File:https://www.sec.gov/Archives/edgar/data/1661998/000110465918070149/0001104659-18-070149-index.htm $Homology Medicines(FIXX)$
查看全文

Homology Medicines(FIXX) 11月28日 11时20分

公告 Homology Medicines, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:5AM Co-Investors IV, L.P.
公告日:2018-11-27, 内部交易人:5AM Co-Investors IV, L.P., 与发行人关系:10%持股人/, 操作:卖出,29682(股)Common Stock,均价$20.0360; 报告日:2018-11-23, SEC Accession No. 0001104659-18-070148, File:https://www.sec.gov/Archives/edgar/data/1661998/000110465918070148/0001104659-18-070148-index.htm $Homology Medicines(FIXX)$
查看全文

Homology Medicines(FIXX) 11月21日 11时59分

公告 Homology Medicines, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:PARMAR KUSH
公告日:2018-11-20, 内部交易人:PARMAR KUSH, 与发行人关系:董事/10%持股人/, 操作:卖出,525900(股)Common Stock,均价$20.2000; 报告日:2018-11-16, SEC Accession No. 0001104659-18-069432, File:https://www.sec.gov/Archives/edgar/data/1661998/000110465918069432/0001104659-18-069432-index.htm $Homology Medicines(FIXX)$
查看全文

Homology Medicines(FIXX) 11月21日 11时59分

公告 Homology Medicines, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:5AM Co-Investors IV, L.P.
公告日:2018-11-20, 内部交易人:5AM Co-Investors IV, L.P., 与发行人关系:10%持股人/, 操作:卖出,525900(股)Common Stock,均价$20.2000; 报告日:2018-11-16, SEC Accession No. 0001104659-18-069431, File:https://www.sec.gov/Archives/edgar/data/1661998/000110465918069431/0001104659-18-069431-index.htm $Homology Medicines(FIXX)$
查看全文

Homology Medicines(FIXX) 11月16日 19时02分

查看全文

Homology Medicines(FIXX) 11月14日 14时56分

新闻 Homology Medicines Reports Third Quarter 2018 Financial Results
On Track to Begin and Report Initial Clinical Data from PKU Gene Therapy Trial and to Start IND-Enabling Studies in PKU Gene ......  url.vc.watch/nqb5
查看全文

Homology Medicines(FIXX) 11月09日 01时17分

新闻 Homology Medicines to Present at Stifel Healthcare Conference
BEDFORD, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq:FIXX), a genetic medicines company, announc ......  url.vc.watch/nlFf
查看全文

Homology Medicines(FIXX) 11月07日 22时57分

新闻 Homology Medicines Presents Data on Platform’s Ability to Target the Central and Peripheral Nervous System and Therapeutic Potential in the Rare Disease Metachromatic Leukodystrophy Homology ......  url.vc.watch/nOQL
查看全文

Homology Medicines(FIXX) 10月20日 01时00分

新闻 Homology Medicines Presents Long-Term Efficacy Data of a Single Dose of Gene Therapy Development Candidate for Treatment of Phenylketonuria BEDFORD, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) - ......  url.vc.watch/Je9W
查看全文

Homology Medicines(FIXX) 10月03日 00时57分

新闻 Homology Medicines to Present at Upcoming Conferences
BEDFORD, Mass., Oct. 1, 2018 /PRNewswire/ -- Homology Medicines, Inc. (Nasdaq:FIXX), a genetic medicines company, announced today that ......  url.vc.watch/JDwY
查看全文

Homology Medicines(FIXX) 09月29日 02时18分

查看全文

Homology Medicines(FIXX) 09月20日 20时42分

查看全文

Homology Medicines(FIXX) 08月30日 22时34分

新闻 Homology Medicines to Participate in Gene Editing Panel at Citi's Biotech Conference
BEDFORD, Mass., Aug. 30, 2018 /PRNewswire/ -- Homology Medicines, Inc. (Nasdaq:FIXX), a genetic med ......  url.vc.watch/jtdQ
查看全文

Homology Medicines(FIXX) 08月16日 07时35分

新闻 Homology Medicines Announces Peer-Reviewed Publication Demonstrating Efficient and Precise In Vivo Gene Editing Capabilities of Nuclease-Free Technology Platform BEDFORD, Mass., July 16, 2 ......  url.vc.watch/jNQy
查看全文

Homology Medicines(FIXX) 08月16日 07时35分

新闻 Homology Medicines Reports Second Quarter 2018 Financial Results
- Company on Track to Begin and Report Initial Data from Phase 1/2 Gene Therapy Program and Advance Gene Editing Platform int ......  url.vc.watch/jNQt
查看全文

Homology Medicines(FIXX) 07月07日 06时44分

新闻 Homology Medicines Added to the Russell 3000® and Russell 2000® Indexes
- Company Will Also Ring the Nasdaq Stock Market Opening Bell Today - BEDFORD, Mass., June 25, 2018 /PRNews ......  url.vc.watch/gv62
查看全文

Homology Medicines(FIXX) 07月07日 06时44分

新闻 Homology Medicines to Present at the National PKU Alliance Conference
BEDFORD, Mass., July 5, 2018 /PRNewswire/ -- Homology Medicines, Inc. (Nasdaq:FIXX), a genetic medicines company, anno ......  url.vc.watch/gv6u
查看全文

Homology Medicines(FIXX) 05月21日 02时52分

新闻 Homology Medicines Reports First Quarter 2018 Financial Results
- Company Completes IPO, Expands Board of Directors and Progresses IND-Enabling Studies to Support a PKU Clinical Gene Therapy ......  url.vc.watch/ftWT
查看全文

Homology Medicines(FIXX) 05月21日 02时52分

新闻 Homology Medicines Presents Data from PKU Gene Therapy Program Demonstrating Long-Term Durability of Treatment in IND-Enabling Studies Presentations Also Demonstrate Phenotypic Correction of ......  url.vc.watch/ftWk
查看全文

Homology Medicines(FIXX) 05月17日 11时01分

查看全文
  • 首页 上一页 1 2 3 下一页 尾页  每页20条/共96